Highland Capital Management (Texas)’s Global Blood Therapeutics, Inc. GBT Stock Holding History

Highland Capital Management (Texas)’s Portfolio GBT Stock Details GBT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	$921K	Hold	17,500	–	–	0.05%	214
2019 Q1	$926K	Sell	17,500 -5,000	-22%	-$246K	0.06%	211
2018 Q4	$924K	Buy	22,500 +7,500	+50%	+$281K	0.07%	161
2018 Q3	$570K	Hold	15,000	–	–	0.03%	207
2018 Q2	$678K	Sell	15,000 -1,000	-6%	-$45.5K	0.04%	185
2018 Q1	$773K	Buy	16,000 +2,400	+18%	+$134K	0.04%	199
2017 Q4	$535K	Buy	+13,600	New	+$508K	0.02%	204
2016 Q3	–	Sell	-82,200	Closed	-$1.36M	–	378
2016 Q2	$1.36M	Buy	+82,200	New	+$1.66M	0.06%	174

Other funds holding GBT

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Highland Capital Management (Texas)'s GBT Position: Q2 2019 in Review

Highland Capital Management (Texas) held its Global Blood Therapeutics, Inc. (GBT) position steady in Q2 2019 at 17,500 shares worth $921K. The position accounts for 0.05% of the portfolio, ranked #214.

Highland Capital Management (Texas) first reported a position in GBT in Q2 2016 and has held it in 8 quarters since. The position peaked at $1.36M in Q2 2016. 223 funds tracked by Wall St. Rank hold GBT as of Q2 2019.

Highland Capital Management (Texas) held 17,500 shares of Global Blood Therapeutics, Inc. worth $921K as of Q2 2019.
Highland Capital Management (Texas) left its Global Blood Therapeutics, Inc. share count unchanged in Q2 2019.
Global Blood Therapeutics, Inc. made up 0.05% of Highland Capital Management (Texas)'s portfolio in Q2 2019, its #214 holding.
Highland Capital Management (Texas) first reported a position in Global Blood Therapeutics, Inc. in Q2 2016 and has held it in 8 quarters since.
Highland Capital Management (Texas)'s Global Blood Therapeutics, Inc. position peaked at $1.36M in Q2 2016.
223 funds tracked by Wall St. Rank held Global Blood Therapeutics, Inc. as of Q2 2019.

Based on Highland Capital Management (Texas)'s 13F filing for Q2 2019, filed 14 Aug 2019.